Allurion Technologies ALURD
ALURD
$3.28 -0.11 (-3.24%)
At close: Aug 18, 2026 · 4:00 PM EDT

Allurion Technologies (ALURD) Total Non-Current Liabilities (2022 - 2026)

Allurion Technologies' (ALURD) quarterly Total Non-Current Liabilities came in at $86.8 million in Q1 2026, down 12.26% YoY from $98.9 million in Q1 2025, and down 6.23% on a QoQ basis from $92.6 million in Q4 2025.

Allurion Technologies (ALURD) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

Allurion Technologies (ALURD) has 5 years of Total Non-Current Liabilities data on file, last reported at $86.8 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 12.26% year-over-year to $86.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.8 million (down 12.26% YoY) and the FY2025 annual result came in at $92.6 million, down 16.43% from the prior year.
  • Total Non-Current Liabilities fell to $86.8 million in Q1 2026, from $92.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $161.4 million in Q3 2023 to a low of -$400000.0 in Q3 2022.
  • A 5-year average of $100.2 million and a median of $102.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities soared 40456.5% — and 2024, when it plunged 35.18%.
  • Tracing ALURD's Total Non-Current Liabilities over 5 years: stood at $81.1 million in 2022, then soared by 66.01% to $134.7 million in 2023, then decreased by 17.75% to $110.8 million in 2024, then dropped by 16.43% to $92.6 million in 2025, then declined by 6.23% to $86.8 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $86.8 million (Q1 2026), $92.6 million (Q4 2025), and $100.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 9.07 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 3.44 Bn
10 Allurion Technologies 49.18 Mn 44.13 Mn 1.23 Mn 86.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 86.81 Mn
Dec 31, 2025 92.58 Mn
Sep 30, 2025 100.25 Mn
Jun 30, 2025 91.22 Mn
Mar 31, 2025 98.94 Mn
Dec 31, 2024 110.77 Mn
Sep 30, 2024 104.64 Mn
Jun 30, 2024 111.52 Mn
Mar 31, 2024 116.35 Mn
Dec 31, 2023 134.69 Mn
Sep 30, 2023 161.43 Mn
Jun 30, 2023 112.49 Mn
Dec 31, 2022 81.13 Mn
Sep 30, 2022 -400,000.00